Management of Patient with Parkinson’s Disease (DBS)

  • Sandra MachadoEmail author


A 78-year-old male, 72 kg, with the diagnosis of medically intractable Parkinson’s disease (PD). PMH significant for multiple hospitalizations for pneumonia, autonomic dysfunction, and depression. Presents with “pill-rolling” tremor, muscular rigidity, postural instability, and bradykinesia. He is currently taking levodopa/carbidopa and selegiline. VS: BP 135/68 lying flat and 105/42 standing up, HR 90, RR 18, satO2 95%. Labs within normal range.


  1. 1.
    Hornykiewicz O. The discovery of dopamine deficiency in the Parkinsonian brain. J Neural Transm Suppl. 2006;70:9–15.Google Scholar
  2. 2.
    Nicholson G, Pereira AC, Hall GM. Parkinson’s disease and anaesthesia. Br J Anaesth. 2002;89(6):904–16.CrossRefGoogle Scholar
  3. 3.
    Ngai SH. Parkinsonism, levodopa, and anesthesia. Anesthesiology. 1972;37(3):344–51.CrossRefGoogle Scholar
  4. 4.
    Birmes P, et al. Serotonin syndrome: a brief review. CMAJ. 2003;168(11):1439–42.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Isbister GK, Buckley NA. The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol. 2005;28(5):205–14.CrossRefGoogle Scholar
  6. 6.
    Shaikh SI, Himanshu V. Parkinson’s disease and anaesthesia. Indian J Anaesth. 2011;55(3):228–34.CrossRefGoogle Scholar
  7. 7.
    Oluigbo CO, Salma A, Rezai AR. Deep brain stimulation for neurological disorders. IEEE Rev Biomed Eng. 2012;5:88–99.CrossRefGoogle Scholar
  8. 8.
    Krack P, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 2003;349(20):1925–34.CrossRefGoogle Scholar
  9. 9.
    Williams NR, Foote KD, Okun MS. STN vs. GPi deep brain stimulation: translating the rematch into clinical practice. Mov Disord Clin Pract. 2014;1(1):24–35.CrossRefGoogle Scholar
  10. 10.
    Miocinovic S, et al. History, applications, and mechanisms of deep brain stimulation. JAMA Neurol. 2013;70(2):163–71.CrossRefGoogle Scholar
  11. 11.
    Rezai AR, et al. Deep brain stimulation for Parkinson’s disease: surgical issues. Mov Disord. 2006;21(Suppl 14):S197–218.CrossRefGoogle Scholar
  12. 12.
    Raz A, et al. Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients. Anesth Analg. 2010;111(5):1285–9.CrossRefGoogle Scholar
  13. 13.
    Krauss JK, et al. Propofol-induced dyskinesias in Parkinson’s disease. Anesth Analg. 1996;83(2):420–2.PubMedGoogle Scholar
  14. 14.
    Venkatraghavan L, Manninen P. Anesthesia for deep brain stimulation. Curr Opin Anaesthesiol. 2011;24(5):495–9.CrossRefGoogle Scholar
  15. 15.
    Elias WJ, et al. Dexmedetomidine and arousal affect subthalamic neurons. Mov Disord. 2008;23(9):1317–20.CrossRefGoogle Scholar
  16. 16.
    Lange M, et al. Anesthesiologic regimen and intraoperative delirium in deep brain stimulation surgery for Parkinson’s disease. J Neurol Sci. 2015;355(1–2):168–73.CrossRefGoogle Scholar
  17. 17.
    Anderson BJ, Marks PV, Futter ME. Propofol--contrasting effects in movement disorders. Br J Neurosurg. 1994;8(3):387–8.CrossRefGoogle Scholar
  18. 18.
    Coubes P, et al. Deep brain stimulation for dystonia. Surgical technique. Stereotact Funct Neurosurg. 2002;78(3–4):183–91.CrossRefGoogle Scholar
  19. 19.
    Venkatraghavan L, Luciano M, Manninen P. Review article: anesthetic management of patients undergoing deep brain stimulator insertion. Anesth Analg. 2010;110(4):1138–45.PubMedGoogle Scholar
  20. 20.
    Machado A, et al. Deep brain stimulation for Parkinson’s disease: surgical technique and perioperative management. Mov Disord. 2006;21(Suppl 14):S247–58.CrossRefGoogle Scholar
  21. 21.
    Machado AG, Deogaonkar M, Cooper S. Deep brain stimulation for movement disorders: patient selection and technical options. Cleve Clin J Med. 2012;79(Suppl 2):S19–24.CrossRefGoogle Scholar
  22. 22.
    Erickson KM, Cole DJ. Anesthetic considerations for awake craniotomy for epilepsy and functional neurosurgery. Anesthesiol Clin. 2012;30(2):241–68.CrossRefGoogle Scholar
  23. 23.
    Canning CG, et al. Parkinson’s disease: an investigation of exercise capacity, respiratory function, and gait. Arch Phys Med Rehabil. 1997;78(2):199–207.CrossRefGoogle Scholar
  24. 24.
    Neu HC, et al. Obstructive respiratory dysfunction in Parkinsonian patients. Am Rev Respir Dis. 1967;95(1):33–47.PubMedGoogle Scholar
  25. 25.
    Trotti LM, Bliwise DL. No increased risk of obstructive sleep apnea in Parkinson’s disease. Mov Disord. 2010;25(13):2246–9.CrossRefGoogle Scholar
  26. 26.
    Easdown LJ, Tessler MJ, Minuk J. Upper airway involvement in Parkinson’s disease resulting in postoperative respiratory failure. Can J Anaesth. 1995;42(4):344–7.CrossRefGoogle Scholar
  27. 27.
    Zrinzo L, et al. Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review. J Neurosurg. 2012;116(1):84–94.CrossRefGoogle Scholar
  28. 28.
    Srejic U, Larson P, Bickler PE. Little black boxes: noncardiac implantable electronic medical devices and their anesthetic and surgical implications. Anesth Analg. 2017;125(1):124–38.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  1. 1.Department of Anesthesiology and Critical Care MedicineCleveland ClinicClevelandUSA

Personalised recommendations